TH and hepatocellular carcinoma: When patients were evaluated to determine the TH status, TSH and FT4 levels were higher in the non-HCC group, with no significant differences (P = .3 and P = .086, respectively), but FT3 levels were significantly higher in the HCC group (P < .001) (Table 2).